307
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures

, , &
Pages 997-1005 | Received 14 Apr 2017, Accepted 24 Jul 2017, Published online: 30 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Stefano de Biase, Gian Luigi Gigli & Mariarosaria Valente. (2020) Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 853-863.
Read now
Jiyuan Li, Meizhen Sun & Xuefeng Wang. (2020) The adverse-effect profile of lacosamide. Expert Opinion on Drug Safety 19:2, pages 131-138.
Read now
Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente & Giovanni Merlino. (2019) Timing use of novel anti-epileptic drugs: is earlier better?. Expert Review of Neurotherapeutics 19:10, pages 945-954.
Read now
Alberto Verrotti, Giulia Iapadre, Giulia Di Donato, Ludovica Di Francesco, Luca Zagaroli, Sara Matricardi, Vincenzo Belcastro & Maria Laura Iezzi. (2019) Pharmacokinetic considerations for anti-epileptic drugs in children. Expert Opinion on Drug Metabolism & Toxicology 15:3, pages 199-211.
Read now
Stefano de Biase, Gian Luigi Gigli, Annacarmen Nilo, Giorgia Romano & Mariarosaria Valente. (2019) Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures. Expert Opinion on Drug Metabolism & Toxicology 15:2, pages 93-102.
Read now

Articles from other publishers (8)

Pengcheng Liu, Mengjiao He, Xiaoli Xu, Yun He, Wenbing Yao & Bin Liu. (2023) Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system. Seizure: European Journal of Epilepsy 110, pages 203-211.
Crossref
Ashutosh Kakkad, B S Keshava, Bashir Ahmadi, GRK Sarma, Praveen Gupta, Rajaram Agarwal, Rajendra Dugani, Rajnish Kumar, Ravindra Lodha, Sanjay Varade, Hitesh Raval, Dhaval Rathod, Shohini Ghosh, Ram Gupta & Krishnaprasad K. (2023) Multi-centric Phase III, single-arm, open-label clinical study to assess clinical safety, tolerability, and efficacy of intravenous lacosamide in focal onset seizures. F1000Research 12, pages 1037.
Crossref
Andreia Carona, Joana Bicker, Rui Silva, Carla Fonseca, Amílcar Falcão & Ana Fortuna. (2021) Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications. Life Sciences 275, pages 119342.
Crossref
Steven J. Walsh, Richard J. Chen, Muhammed Ershad & James A. Krueger. (2020) The Toxicity of Newer and Lesser-Known Anticonvulsant Drugs. Current Emergency and Hospital Medicine Reports 8:4, pages 142-150.
Crossref
H. A. El-Sabagh, M. I. Aydia, A. M. Amin & K. M. El-Azony. (2020) Radiolabeling of lacosamide using highly purified rhenium-188 as a prospective brain theranostic agent. Nuclear Science and Techniques 31:10.
Crossref
Cecilie Johannessen Landmark & Svein I. Johannessen. 2020. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics 225 256 .
Clare E. Stevens & Carl E. Stafstrom. (2018) Pharmacotherapy for Focal Seizures in Children and Adolescents. Drugs 78:13, pages 1321-1337.
Crossref
Alan B. Ettinger, John A. Carter & Krithika Rajagopalan. (2018) Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies. Epilepsy & Behavior 80, pages 247-253.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.